On October 2, ASYMCHEM fell 3.35% in regular trading, trading at 162.2 HKD/share, with turnover of 7.9406 million HKD.

Within the Pharmaceuticals sector where ASYMCHEM belongs, the overall sector trended weaker. Among individual stocks, HANSOH PHARMA down 4.31%, HENGRUI PHARMA down 4.30%, SIMCERE PHARMA down 4.64%, SBP GROUP down 3.77%, CSPC PHARMA down 3.48%.

ASYMCHEM is a China-based company principally engaged in providing one-stop comprehensive pharmaceutical outsourcing services. Its businesses include small molecule CDMO, chemical macromolecule CDMO, clinical research services, formulation CDMO, and biological macromolecule CDMO. Its product categories cover peptides, oligonucleotides, monoclonal antibodies, antibody-drug conjugates, and messenger RNA, among others.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)